BIOY.US GraniteShares YieldBOOST Biotech ETF
- Total assets
- 2.11M
- Expense ratio
- -
- Dividend yield
- -
- 1-year return
- -
- Holdings
- 1
- Since
- 2026
Fund data as reported by the issuer, updated Nov 12, 2026. Total assets are in the fund's base currency.
What does BIOY.US invest in?
- Mostly Cash (76.1%)
Asset allocation
- Cash 76.1%
- Bonds 29.4%
GraniteShares YieldBOOST Biotech ETF performance
Sharpe ratio 0.00Return figures of GraniteShares YieldBOOST Biotech ETF are not available yet.
BIOY.US price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
About GraniteShares YieldBOOST Biotech ETF
It is an actively managed exchange-traded fund ("ETF") that seeks to pay weekly distributions by selling put options on the Underlying Leveraged ETF, which provides exposure to 3 times the daily performance of the underlying index. The fund is non-diversified.
Full fund profileGraniteShares YieldBOOST Biotech ETF top holdings
The holdings of GraniteShares YieldBOOST Biotech ETF are not available yet.
GraniteShares YieldBOOST Biotech ETF fund profile
- Fund name
- GraniteShares YieldBOOST Biotech ETF
- Ticker
- BIOY.US
- Exchange
- USA Stocks
- Issuer
- Graniteshares
- Index tracked
- -
- Category
- -
- Inception date
- May 4, 2026
- Trading currency
- USD
- Expense ratio
- -
- Dividends paid
- Weekly
About GraniteShares YieldBOOST Biotech ETF
It is an actively managed exchange-traded fund ("ETF") that seeks to pay weekly distributions by selling put options on the Underlying Leveraged ETF, which provides exposure to 3 times the daily performance of the underlying index. The fund is non-diversified.